Showing 37 to 48 of 211 results
Healthy Diet Improves Cardiometabolic Health Regardless of Weight Loss
A study of 761 obese participants following three different diets found that even those who didn't lose weight experienced significant improvements in cardiometabolic health markers, emphasizing the importance of diet quality regardless of weight change.
Healthy Diet Improves Cardiometabolic Health Regardless of Weight Loss
A study of 761 obese participants following three different diets found that even those who didn't lose weight experienced significant improvements in cardiometabolic health markers, emphasizing the importance of diet quality regardless of weight change.
Progress
16% Bias Score
UK introduces healthy food standard to tackle obesity crisis
The UK government announced a new healthy food standard for supermarkets and retailers, aiming to reduce obesity-related NHS costs by \£11 billion annually by incentivizing healthier food choices. Supermarkets will report sales data and face penalties if targets aren't met.
UK introduces healthy food standard to tackle obesity crisis
The UK government announced a new healthy food standard for supermarkets and retailers, aiming to reduce obesity-related NHS costs by \£11 billion annually by incentivizing healthier food choices. Supermarkets will report sales data and face penalties if targets aren't met.
Progress
36% Bias Score
Wegovy's 7.2mg Dose Shows 20.7% Weight Loss in Obese Individuals: Novo Nordisk
Novo Nordisk's STEP UP trial, presented at the ADA 2024 Scientific Sessions, demonstrated that a 7.2mg dose of semaglutide (Wegovy) led to a 20.7% average weight loss in obese individuals without diabetes after 72 weeks, with a third achieving at least 25% weight reduction compared to placebo; the c...
Wegovy's 7.2mg Dose Shows 20.7% Weight Loss in Obese Individuals: Novo Nordisk
Novo Nordisk's STEP UP trial, presented at the ADA 2024 Scientific Sessions, demonstrated that a 7.2mg dose of semaglutide (Wegovy) led to a 20.7% average weight loss in obese individuals without diabetes after 72 weeks, with a third achieving at least 25% weight reduction compared to placebo; the c...
Progress
52% Bias Score
Novo Nordisk's Obesity Campaign Backfires Amidst Public Outrage
Novo Nordisk's Madrid campaign, labeling obesity a deadly disease, sparked controversy due to its aggressive tone and perceived promotion of Ozempic, despite support from some scientific societies who now express concern.
Novo Nordisk's Obesity Campaign Backfires Amidst Public Outrage
Novo Nordisk's Madrid campaign, labeling obesity a deadly disease, sparked controversy due to its aggressive tone and perceived promotion of Ozempic, despite support from some scientific societies who now express concern.
Progress
60% Bias Score
China Expands TCM Pediatric Services to Combat Childhood Obesity
China will require all tertiary and at least 80 percent of secondary public traditional Chinese medicine hospitals to establish pediatric departments by November 2024, expanding access to TCM pediatric care and addressing rising childhood obesity rates.
China Expands TCM Pediatric Services to Combat Childhood Obesity
China will require all tertiary and at least 80 percent of secondary public traditional Chinese medicine hospitals to establish pediatric departments by November 2024, expanding access to TCM pediatric care and addressing rising childhood obesity rates.
Progress
32% Bias Score
Wegovy Use Among Teens Increases by 50% in 2024
Data shows a 50% increase in Wegovy prescriptions for American teens in 2024, reaching 14.8 per 100,000 adolescents, despite concerns about long-term effects and limited insurance coverage; this follows a strong recommendation from the American Academy of Pediatrics in January 2023.
Wegovy Use Among Teens Increases by 50% in 2024
Data shows a 50% increase in Wegovy prescriptions for American teens in 2024, reaching 14.8 per 100,000 adolescents, despite concerns about long-term effects and limited insurance coverage; this follows a strong recommendation from the American Academy of Pediatrics in January 2023.
Progress
36% Bias Score
UK Supermarkets Ordered to Cut 100 Calories from Average Basket
UK supermarkets face pressure to cut 100 calories from average shopping baskets to combat obesity, potentially saving the NHS £5 billion annually; political reactions range from 'nanny state' criticisms to support for linking weight loss to reduced hospital waiting times.
UK Supermarkets Ordered to Cut 100 Calories from Average Basket
UK supermarkets face pressure to cut 100 calories from average shopping baskets to combat obesity, potentially saving the NHS £5 billion annually; political reactions range from 'nanny state' criticisms to support for linking weight loss to reduced hospital waiting times.
Progress
64% Bias Score
Spain Investigates Novo Nordisk for Potentially Illegal Weight-Loss Drug Advertising
Spain is investigating Novo Nordisk for potentially illegal advertising of its weight-loss drugs Ozempic and Wegovy, following similar accusations in Ireland and the UK, prompting concerns about pharmaceutical marketing tactics and their impact on national health budgets.
Spain Investigates Novo Nordisk for Potentially Illegal Weight-Loss Drug Advertising
Spain is investigating Novo Nordisk for potentially illegal advertising of its weight-loss drugs Ozempic and Wegovy, following similar accusations in Ireland and the UK, prompting concerns about pharmaceutical marketing tactics and their impact on national health budgets.
Progress
48% Bias Score
Genetic Factors Significantly Influence Weight Loss Response to Healthy Diets
A new study involving 761 Israeli adults with abdominal obesity found that despite following various healthy diets for 18-24 months, 28% experienced no weight loss, yet still showed significant improvements in cardio-metabolic health, suggesting that genetic factors play a significant role in weight...
Genetic Factors Significantly Influence Weight Loss Response to Healthy Diets
A new study involving 761 Israeli adults with abdominal obesity found that despite following various healthy diets for 18-24 months, 28% experienced no weight loss, yet still showed significant improvements in cardio-metabolic health, suggesting that genetic factors play a significant role in weight...
Progress
64% Bias Score
Weight Stigma: Counterproductive to Weight Loss and Harmful to Mental Health
Research reveals that weight stigma, a pervasive misconception that weight is entirely self-controlled, is counterproductive to weight loss and harms mental health by increasing risks of depression, anxiety, and disordered eating; those with less stigma were more likely to maintain weight loss after...
Weight Stigma: Counterproductive to Weight Loss and Harmful to Mental Health
Research reveals that weight stigma, a pervasive misconception that weight is entirely self-controlled, is counterproductive to weight loss and harms mental health by increasing risks of depression, anxiety, and disordered eating; those with less stigma were more likely to maintain weight loss after...
Progress
20% Bias Score
15 Million Undiagnosed Cases of Aggressive Fatty Liver Disease in US and Europe
Research reveals that over 15 million people in the US, UK, Germany, and France are undiagnosed with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, resulting in significant economic and health consequences; improved screening, treatment, and...
15 Million Undiagnosed Cases of Aggressive Fatty Liver Disease in US and Europe
Research reveals that over 15 million people in the US, UK, Germany, and France are undiagnosed with metabolic dysfunction-associated steatohepatitis (MASH), the most aggressive form of fatty liver disease, resulting in significant economic and health consequences; improved screening, treatment, and...
Progress
40% Bias Score
Ozempic Weight Loss Drugs Linked to Increased Kidney Cancer Risk
A major study of 86,000 patients revealed that while weight-loss drugs like Ozempic lower the risk of 16 cancers by 17 percent, they may increase kidney cancer risk by 33 percent, prompting calls for further research.
Ozempic Weight Loss Drugs Linked to Increased Kidney Cancer Risk
A major study of 86,000 patients revealed that while weight-loss drugs like Ozempic lower the risk of 16 cancers by 17 percent, they may increase kidney cancer risk by 33 percent, prompting calls for further research.
Progress
60% Bias Score
Showing 37 to 48 of 211 results